Last reviewed · How we verify

NCT03799705

Genetic Variants in Nicotinamide Adenine Dinucleotide (NAD) Synthesis Pathway

Completed Last updated 19 April 2024
What this trial tests

trial in Vacterl Association in 132 participants. Completed in 1 December 2022.

Timeline
1 December 2019
Primary endpoint
1 December 2022
1 December 2022

Quick facts

Lead sponsorMayo Clinic
StatusCompleted
Study typeOBSERVATIONAL
Enrollment132
Start date1 December 2019
Primary completion1 December 2022
Estimated completion1 December 2022
Sites1 location across United States

Conditions studied

Sponsor

Mayo Clinic

Who can join

0 and older, any sex, with Vacterl Association or Congenital Malformation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Researchers are trying to identify versions of genes as well as factors in subjects blood associated with certain types of congenital malformations(CMs). This study will help the researchers to better understand family traits that contribute to CMs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Mayo Clinic trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03799705.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing